| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/30/2001 | US6180131 Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals |
| 01/30/2001 | US6180116 Histidine derivatives, preparation process and uses |
| 01/30/2001 | US6180113 Used in tumor therapy and interventional radiology |
| 01/30/2001 | US6180101 Remedy for axillary osmidrosis containing adrenocorticosteroidal preparation |
| 01/30/2001 | US6180094 Remedies for hyperphosphatemia |
| 01/30/2001 | US6180093 As lubricant for contact lenses or dry eye |
| 01/30/2001 | US6180087 Tunable indocyanine dyes for biomedical applications |
| 01/30/2001 | US6180085 Useful for optical tomographic, endoscopic, photoacoustic and sonofluoresence applications for detection and treatment of tumors and other abnormalities |
| 01/30/2001 | US6179883 2-imino-2,3-dihydro-1H-indole derivatives for dyeing keratin fibers |
| 01/30/2001 | CA2313825A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 01/30/2001 | CA2272317C Pharmaceutical composition comprising a compound having anti-xa activity and a platelet aggregation antagonist compound |
| 01/30/2001 | CA2238098C Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 01/30/2001 | CA2191352C Quinoline derivatives as tachykinin nk3 receptor antagonists |
| 01/30/2001 | CA2148112C New pharmaeutical dosage form for transdermal administration |
| 01/30/2001 | CA2145640C Substituted pyrimidines for control of diabetic complications |
| 01/30/2001 | CA2053268C Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| 01/30/2001 | CA2021637C Complexes of neolignane derivatives with phospholipids, the use thereof and pharmaceutical and cosmetic formulations containing them |
| 01/30/2001 | CA2011637C Compositions for the sustained-release of chlorhexidine |
| 01/29/2001 | CA2314682A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 01/29/2001 | CA2280925A1 Stabilized cefuroxime axetil |
| 01/29/2001 | CA2279134A1 Novel strategy for carbohydrate-based therapeutic vaccines |
| 01/28/2001 | CA2314572A1 Estrogen agonists and antagonists for multiple indications |
| 01/26/2001 | CA2314418A1 Incorporation of cholesterol lowering agents into confectionery dosage forms |
| 01/25/2001 | WO2001006756A2 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes |
| 01/25/2001 | WO2001006018A1 Antisense modulation of map kinase kinase 6 expression |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001006010A1 Antisense modulation of telomeric repeat binding factor 1 expression |
| 01/25/2001 | WO2001005993A1 Cellular absorption of dna |
| 01/25/2001 | WO2001005983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | WO2001005970A2 Gtp-binding protein associated factors |
| 01/25/2001 | WO2001005958A1 Antisense modulation of p13 kinase p110 delta expression |
| 01/25/2001 | WO2001005954A1 Antisense modulation of liver glycogen phosphorylase expression |
| 01/25/2001 | WO2001005947A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | WO2001005937A2 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/25/2001 | WO2001005831A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | WO2001005806A1 Orally active androgens |
| 01/25/2001 | WO2001005805A2 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 01/25/2001 | WO2001005802A1 Antisense modulation of fadd expression |
| 01/25/2001 | WO2001005797A1 Titanium derived compounds, preparation and use thereof |
| 01/25/2001 | WO2001005795A1 Remedies or preventives for frequent urination or urinary incontinence |
| 01/25/2001 | WO2001005794A2 Method for making debromohymenialdisine and analogs thereof |
| 01/25/2001 | WO2001005793A1 1,2,3,4,5,6-HEXAHYDROAZEPINO[4,5-b]INDOLES CONTAINING ARYLSULFONES AT THE 9-POSITION |
| 01/25/2001 | WO2001005792A1 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 01/25/2001 | WO2001005791A2 NEW PROCESS FOR THE PREPARATION OF N-(1,1-DIMETHYLETHYL)-4-[[5'-ETHOXY-4-cis-[2-(4-MORFOLINO)ETHOXY]-2'-OXOSPIRO[CYCLOHEXAN-1,3'-[H]INDOL]-1'(2'H)-yl]-SULFONYL]-3-METHOXYBENZAMIDE AND ITS SALTS |
| 01/25/2001 | WO2001005790A1 New compounds |
| 01/25/2001 | WO2001005784A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR Xa INHIBITORS |
| 01/25/2001 | WO2001005783A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | WO2001005782A1 Novel diphenyl-piperidine derivate |
| 01/25/2001 | WO2001005776A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 01/25/2001 | WO2001005773A1 Conjugates of sodium channel blockers and methods of using the same |
| 01/25/2001 | WO2001005772A1 Pyrazinones, compositions containing such compounds |
| 01/25/2001 | WO2001005771A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | WO2001005770A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | WO2001005769A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/25/2001 | WO2001005768A1 Tricyclic compounds bearing acyloxymethoxycarbonyl pendants |
| 01/25/2001 | WO2001005765A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
| 01/25/2001 | WO2001005764A2 Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester |
| 01/25/2001 | WO2001005762A2 Biphenyl derivatives, production thereof and use as mtp inhibitors |
| 01/25/2001 | WO2001005761A1 sPLA2 INHIBITORS |
| 01/25/2001 | WO2001005758A2 Indoles and indazoles for the treatment of migraine |
| 01/25/2001 | WO2001005756A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 01/25/2001 | WO2001005753A1 Diacylhydrazine derivatives |
| 01/25/2001 | WO2001005751A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005749A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005746A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005745A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005744A1 Novel aminobenzophenones |
| 01/25/2001 | WO2001005743A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
| 01/25/2001 | WO2001005742A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 01/25/2001 | WO2001005435A2 Antisense therapy for hormone-regulated tumors |
| 01/25/2001 | WO2001005431A1 Taste masking of oral quinolone liquid preparations using ion exchange resins |
| 01/25/2001 | WO2001005430A1 Sustained release drug dispersion delivery device |
| 01/25/2001 | WO2001005428A1 Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof |
| 01/25/2001 | WO2001005427A1 Psca: prostate stem cell antigen and uses thereof |
| 01/25/2001 | WO2001005425A2 Combined preparations comprising daunorubicin derivatives and her2 antibodies |
| 01/25/2001 | WO2001005422A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 01/25/2001 | WO2001005414A1 Algae protein polysaccharide extraction and use thereof |
| 01/25/2001 | WO2001005411A1 Compositions addressing inflammation and/or degenerative disorders |
| 01/25/2001 | WO2001005408A1 Fat-binding polymers, optionally combined with lipase inhibitors |
| 01/25/2001 | WO2001005407A1 Rapid immediate release oral dosage form |
| 01/25/2001 | WO2001005404A1 Use of beta-napthoquinone for making medicines having an inhibiting effect on the release of glutamate by the brain |
| 01/25/2001 | WO2001005403A1 Drugs for periodontal diseases |
| 01/25/2001 | WO2001005402A1 Preventive and therapeutic agents for cancer |
| 01/25/2001 | WO2001005401A1 Melanocortin receptor-3 ligands to treat sexual dysfunction |
| 01/25/2001 | WO2001005400A1 Nitroimidazole external preparations for dermatosis |
| 01/25/2001 | WO2001005399A1 Anti-ischemic agent |
| 01/25/2001 | WO2001005398A1 Phosphate transport inhibitors |
| 01/25/2001 | WO2001005397A1 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 01/25/2001 | WO2001005396A1 Use of cobalt chelates for treating or preventing virus infection |
| 01/25/2001 | WO2001005395A1 Selective inhibition of cyclooxygenase-2 |
| 01/25/2001 | WO2001005394A1 Agents inhibiting chronic rejection reactions after organ transplantation |
| 01/25/2001 | WO2001005393A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005392A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005391A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005390A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005389A2 N-sulfonylaminiacid derivatives as inhibitors of metalloprteinase |
| 01/25/2001 | WO2001005388A2 Use of a fatty derivative for the treatment of external secretiondisorders |
| 01/25/2001 | WO2001005387A2 Pharmaceutical composition containing trichloroacetic acid, 2-oh benzoic and menthol for topical application, uses and process for the preparation thereof |
| 01/25/2001 | WO2001005386A2 Pharmaceutical composition useful for the treatment of tinnitus and hearing loss |
| 01/25/2001 | WO2001005385A2 New use of a macrolide compound for treating neurodegenerative disorders |